IDEAYA Biosciences, Inc.
Assets & Liabilities
| Period | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| Dec 2016 | — | — | $9.7M |
| Dec 2017 | — | — | $6.0M |
| Jun 2018 | — | — | $24.9M |
| Sep 2018 | — | — | $21.5M |
| Dec 2018 | $7.1M | $96.5M | $20.5M |
| Mar 2019 | — | — | $35.3M |
| Jun 2019 | $12.8M | $133.4M | $88.1M |
| Sep 2019 | $11.9M | $122.3M | $38.8M |
| Dec 2019 | $12.6M | $113.0M | $34.1M |
| Mar 2020 | $12.7M | $101.8M | $35.5M |
| Jun 2020 | $12.5M | $184.5M | $147.5M |
| Sep 2020 | $106.0M | $301.4M | $81.2M |
| Dec 2020 | $100.0M | $298.3M | $72.0M |
| Mar 2021 | $93.0M | $326.1M | $136.8M |
| Jun 2021 | $88.1M | $328.4M | $90.4M |
| Sep 2021 | $81.8M | $399.4M | $108.4M |
| Dec 2021 | $79.8M | $381.3M | $92.0M |
| Mar 2022 | $70.2M | $358.9M | $55.3M |
| Jun 2022 | $68.7M | $338.0M | $49.1M |
| Sep 2022 | $42.1M | $410.9M | $102.0M |
| Dec 2022 | $38.5M | $388.0M | $68.6M |
| Mar 2023 | $30.9M | $364.7M | $67.2M |
| Jun 2023 | $25.9M | $527.6M | $102.8M |
| Sep 2023 | $24.9M | $532.9M | $151.9M |
| Dec 2023 | $28.2M | $649.3M | $157.0M |
| Mar 2024 | $26.2M | $961.5M | $108.3M |
| Jun 2024 | $42.0M | $973.7M | $183.0M |
| Sep 2024 | $59.5M | $1.24B | $400.3M |
| Dec 2024 | $64.9M | $1.12B | $84.4M |
| Mar 2025 | $76.5M | $1.10B | $130.0M |
| Jun 2025 | $81.6M | $1.04B | $114.6M |
| Sep 2025 | $93.1M | $1.19B | $298.9M |
| Dec 2025 | $86.4M | $1.11B | $112.8M |
| Mar 2026 | $93.1M | $1.03B | $157.5M |
| Jun 2026 | $110.8M | $1.31B | $272.6M |